What is Supernus Pharmaceuticals's capex?

Supernus Pharmaceuticals (SUPN) reported capex of $0 in Q1 2026.

How has Supernus Pharmaceuticals's capex changed year-over-year?

Supernus Pharmaceuticals's capex decreased by 100.0% year-over-year, from $327K to $0.

What is the long-term trend for Supernus Pharmaceuticals's capex?

Over 2 years (2023 to 2025), Supernus Pharmaceuticals's capex has grown at a 51.0% compound annual growth rate (CAGR), from $587K to $1.34M.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Supernus Pharmaceuticals SUPN CapEx

CapEx at other companies

AbbVieABBV

$265M+12.8%

Rapport Therapeutics, Inc.RAPP

$86K-70.4%

Axsome TherapeuticsAXSM

$121K-64.2%

Neurocrine BiosciencesNBIX

$9.1M-15.0%

Jazz PharmaceuticalsJAZZ

$19.7M+41.7%

Acadia PharmaceuticalsACAD

$5.21M—

Other financials

Income statement

See full

Revenue$207.7M+38.6%

Gross profit$184.3M+37.5%

Operating income-$8.3M+18.8%

Net income-$2.3M+80.6%

EPS (diluted)-$0.04+81.0%

Balance sheet

See full

Cash & equivalents$186.3M+60.8%

Total debt$40.9M+26.6%

Total equity$1.1B+4.5%

Total assets$1.5B+11.4%

Cash flow

See full

Operating cash flow$66.5M+117%

Free cash flow$66.5M+120%

Valuation

See full

Market cap$2.58B+62.8%

Enterprise value$2.44B+62.3%

P/S3.3×+0.9×

Profitability

See full

Gross margin89.4%+1.0pp

Operating margin-7.8%-18.9pp

Net margin-3.7%-13.0pp

FCF margin27.9%+3.4pp

Returns & leverage

See full

Return on equity-2.8%-9.1pp

Debt / equity0×0.0×

Current ratio2×-0.5×

Where this comes from

Reported directly by Supernus Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Supernus Pharmaceuticals's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Supernus Pharmaceuticals's capex?: Supernus Pharmaceuticals (SUPN) reported capex of $0 in Q1 2026.
How has Supernus Pharmaceuticals's capex changed year-over-year?: Supernus Pharmaceuticals's capex decreased by 100.0% year-over-year, from $327K to $0.
What is the long-term trend for Supernus Pharmaceuticals's capex?: Over 2 years (2023 to 2025), Supernus Pharmaceuticals's capex has grown at a 51.0% compound annual growth rate (CAGR), from $587K to $1.34M.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.